The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Share News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.90
Bid: 29.10
Ask: 30.70
Change: 0.10 (0.34%)
Spread: 1.60 (5.498%)
Open: 29.80
High: 0.00
Low: 0.00
Prev. Close: 29.80
EKF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Concepta Unveils Genomic Covid-19 Test And Plans Name Change

Wed, 02nd Dec 2020 09:55

(Alliance News) - Concepta PLC on Wednesday said it has launched a Covid-19 genomic testing kit, and the myLotus pregnancy test maker also outlined plans for a name change.

Shares in Concepta jumped 32% to 2.12 pence each in London on Wednesday morning.

The healthcare company and fertility tracking firm launched a DNA testing service under the MyHealthChecked brand, in the wake of Concepta's acquisition of Genome Store Ltd, announced in November.

Concepta parted with an initial GBP280,000 to buy the home-use genetic testing company, plus a deferred consideration of up to GBP240,000.

The company said the test will be a "COVID-19 lab-based PCR test".

"The MyHealthChecked Covid-19 testing service will use the Clarigene SARS-CoV-2 test supplied by Yourgene Health PLC and the PrimeStore MTM sample collection device supplied by EKF Diagnostic Holdings PLC," Concepta added.

"The MyHealthChecked testing service allows samples to be quickly and conveniently taken at home using simple nasal collection swabs which are then sent via free postage for processing using established laboratory-based DNA and RNA detection methods."

Looking ahead, Concepta said it plans to launch a "number of DNA tests", in fields such as male and female wellness and food intolerance.

"Our priority is to look beyond the pandemic with a range of affordable, meaningful at-home test kits, but it would be remiss of us - now with the expertise and operational channel in-house - not to make this kit available to the public," Concepta Chief Executive Officer Penny McCormick said.

The company added that the "requirement for at home testing kits is expected to continue", despite promising news on the vaccine front.

The UK government on Wednesday said it has authorised Pfizer Inc and BioNTech SE's Covid-19 vaccine, becoming the first country in the world to give the jab the green light.

In changes that will take effect in "due course" Concepta said its name will change to MyHealthChecked PLC.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
19 May 2021 10:12

EKF Diagnostics trading well as it starts looking beyond pandemic

(Sharecast News) - Point-of-care company EKF Diagnostics updated the market on its trading on Wednesday, following its most successful year to date in 2020, with record turnover and profits.

Read more
18 May 2021 17:38

Trellus Health plans GBP25 million IPO on London's AIM

Trellus Health plans GBP25 million IPO on London's AIM

Read more
18 May 2021 10:28

Ex-EKF investee Trellus confirms intention to list on AIM

(Sharecast News) - EKF Diagnostics' former investree, connected health technology company Trellus Health, confirmed its intention to seek admission of its shares to trading on AIM.

Read more
12 May 2021 16:04

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
9 May 2021 18:47

Sunday share tips: Trident Royalties, EKF Diagnostics

(Sharecast News) - The Financial Mail on Sunday's Midas column recommends buying stock in Trident Royalties, touting soaring metals' prices and "bright" prospects.

Read more
30 Apr 2021 16:39

IN BRIEF: EKF Diagnostics non-executive director sells 500,000 shares

IN BRIEF: EKF Diagnostics non-executive director sells 500,000 shares

Read more
22 Apr 2021 15:22

DIRECTOR DEALINGS: EKF Diagnostics chair sells; Flowtech chair buys

DIRECTOR DEALINGS: EKF Diagnostics chair sells; Flowtech chair buys

Read more
30 Mar 2021 14:31

IN BRIEF: EKF Diagnostics 2020 earnings rise, signs two-year contract

IN BRIEF: EKF Diagnostics 2020 earnings rise, signs two-year contract

Read more
23 Mar 2021 16:07

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
17 Jan 2021 19:56

Sunday share tips: N Brown, Foxtons

(Sharecast News) - The Financial Mail on Sunday's Midas column touted a raft of shares which it expected would benefit from the fight against obesity as well as the associated, and sometimes fatal, health risks.

Read more
12 Jan 2021 11:47

IN BRIEF: Payout Eyed At EKF On Covid Sample Collection Device Demand

IN BRIEF: Payout Eyed At EKF On Covid Sample Collection Device Demand

Read more
3 Dec 2020 16:13

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
26 Nov 2020 18:00

UK TRADING UPDATE SUMMARY: Chesterfield Lands Polymetal Investment

UK TRADING UPDATE SUMMARY: Chesterfield Lands Polymetal Investment

Read more
26 Nov 2020 14:53

EKF partner Kantaro gets FDA authorisation for Covid-19 test

(Sharecast News) - Point-of-care company EKF Diagnostics updated the market on developments at its partner Kantaro Biosciences on Thursday, confirming that it had received Emergency Use Authorization from the US Food and Drug Administration (FDA) for 'COVID-SeroKlir', its semi-quantitative SARS-CoV-2 IgG antibody test kit.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.